Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Catheter Precision's Enterprise Value is $13.27 Mil.
Catheter Precision's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-16.25 Mil. Therefore, Catheter Precision's EV-to-EBIT ratio for today is -0.82.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Catheter Precision's Enterprise Value is $13.27 Mil.
Catheter Precision's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-14.19 Mil. Therefore, Catheter Precision's EV-to-EBITDA ratio for today is -0.94.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Catheter Precision's Enterprise Value is $13.27 Mil.
Catheter Precision's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $1.11 Mil. Therefore, Catheter Precision's EV-to-Revenue ratio for today is 11.97.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Catheter Precision (AMEX:VTAK) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Catheter Precision's current Enterprise Value is $13.27 Mil.
Catheter Precision's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.25 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Catheter Precision's current Enterprise Value is $13.27 Mil.
Catheter Precision's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.19 Mil.
Catheter Precision's current Enterprise Value is $13.27 Mil.
Catheter Precision's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.11 Mil.
Catheter Precision's current Enterprise Value is $13.27 Mil.
Catheter Precision's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.75 Mil.
Catheter Precision's current Enterprise Value is $13.27 Mil.
Catheter Precision's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision Enterprise Value Related Terms
Catheter Precision Enterprise Value Historical Data
* Premium members only.
The historical data trend for Catheter Precision's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VTAK vs ALURD, BJDX, AMIX: Enterprise Value Comparison
For the Medical Devices subindustry, Catheter Precision's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Catheter Precision's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Catheter Precision's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision (VTAK) has a Enterprise Value of $13.27 Mil as of Jul. 04, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Catheter Precision and its competitors.
Is Catheter Precision's Enterprise Value too high?
Catheter Precision's current Enterprise Value is $13.27 Mil. Overall, Catheter Precision has a GF Score™ of 23/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's Enterprise Value compare to ALURD and BJDX?
Catheter Precision's Enterprise Value of $13.27 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Catheter Precision and its competitors. Catheter Precision's current Enterprise Value is $13.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Based on GuruFocus' analysis, Catheter Precision (VTAK) is currently considered Possible Value Trap. The stock's GF Value™ is $1.71, compared to a current price of $0.79 — trading 53.8% below its estimated fair value. The current Enterprise Value is $13.27 Mil. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Catheter Precision (VTAK), the current Enterprise Value is $13.27 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Catheter Precision (VTAK) Overvalued in 2026?
Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued.
The current stock price of $0.79 is trading 53.8% below its estimated GF Value™ of $1.71.
GuruFocus considers Catheter Precision to be Possible Value Trap.
Key valuation signals for VTAK:
Enterprise Value: $13.27 Mil
GF Value™: $1.71 vs. price of $0.79 (53.8% below fair value)
No single metric tells the full story. See the VTAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score
Get the complete analysis for VTAK
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTAK has been successfully added to your 
